16 research outputs found
Univariate analysis of clinical predictors for in-hospital mortality.
<p>* Due to the occurrence of missing data found in <2% of the variables, numbers may not add up to total n.</p><p>†Compared to the normal range of temperature (i.e., 35.5–37.5°C).</p><p>∞ Compared to the normal range of WBC (i.e., 4,000–12,000 cells/ml).</p><p>n/a = not applicable.</p
Number and percentage of organisms grown from aerobic blood culture.
<p>Number and percentage of organisms grown from aerobic blood culture.</p
Frequency of separate empiric antibiotic regimens used.
<p>[*Represents 35 separate regimens used <1% of the time; Pen/Gent = Penicillin/Gentamicin; Pen/TMP-SMX = Penicillin/Trimethoprim-Sulfamethoxazole; Amp/Metro = Ampicillin/Metronidazole, Amp/Gent = Ampicllin/Gentamicin, Chlor/Pen = Chloramphenicol/Penicillin; Cipro/TMP-SMX = Ciprofloxacin/Trimethoprim-Sulfamethoxazole, Cipro/Metro = Ciprofloxacin/Metronidazole; TMP-SMX = Trimethoprim-Sulfamethoxazole]</p
Descriptive characteristics of hospital sites.
<p>* Due to the occurrence of missing data found in <2% of the variables, numbers may not add up to total n.</p><p>†Denominator is Number HIV-infected.</p><p>∞ Portable whole blood lactate levels were not obtained on all patients [combined (n = 194); Mulago (n = 70); Masaka (n = 124)].</p
Multivariate analysis of clinical predictors for in-hospital mortality.
<p>* Per 10-unit increase.</p><p>∞ Compared to the normal range of WBC (i.e., 4,000–12,000 cells/ml).</p
Multivariate analysis of clinical predictors for post-discharge mortality.
<p>* Per 10-unit increase.</p
In-hospital mortality and admission Karnofsky Performance Scale score.
<p>[*Numbers in bars represent number of patients.]</p
Univariate analysis of clinical predictors for post-discharge mortality.
<p>* Due to the occurrence of missing data found in <2% of the variables, numbers may not add up to total n.</p><p>†Compared to the normal range of temperature (i.e., 35.5–37.5°C).</p><p>∞ Compared to the normal range of WBC (i.e., 4,000–12,000 cells/ml).</p><p>n/a = not applicable.</p
Frequencies of biomarker testing, including 13 tests on plasma, 4 on fecal and L/M absorption testing on urine as shown.
<p>*Of 326 children with samples obtained within 1 month of study start.</p
Heat map showing all significant partial Pearson correlations of barrier and systemic biomarkers with HAZ or WAZ at enrollment (ie. study start, ss) or with changes in (Δ) HAZ or WAZ.
<p>Significant correlations (at p<0.05; * = p<0.01) between biomarkers and growth, controlling for child age and gender. HAZ = height for age Z score; WAZ = weight for age z score; ss = study start; Δ = change in HAZ or WAZ at 2-6m followup; numbers range from 230 to 292 except for zonulin at age >12m where n = 172. Full r, p and df values are provided in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0158772#pone.0158772.s002" target="_blank">S1 Table</a>.</p